Crispr Therapeutics shares owned by Stone House Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Stone House Investment Management
from 13F filings
Historical chart of Stone House Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Stone House Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $22k | 460 | 46.98 |
| 2024-03-31 | $39k | 569 | 68.16 |
| 2023-12-31 | $11k | 169 | 62.60 |
| 2023-09-30 | $8.9k | 196 | 45.39 |
| 2023-06-30 | $11k | 196 | 56.14 |
| 2023-03-31 | $8.9k | 196 | 45.23 |
More positions owned by Stone House Investment Management
View all positions for Stone House Investment Management